Meningococcal B vaccination also cuts risk of gonorrhoea, study suggests
BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3350 (Published 11 July 2017) Cite this as: BMJ 2017;358:j3350- Susan Mayor
- London
People vaccinated with an outer membrane vesicle (OMV) group B meningococcal vaccine showed a 30% lower risk of gonorrhoea diagnosis in a large study, suggesting that vaccination provides a new approach for preventing gonorrhoea.1
Although very different diseases, an 80-90% genetic match exists between the bacterium that causes meningococcal disease (Neisseria meningitidis) and the gonorrhoea pathogen Neisseria gonorrhoeae. Observational surveillance data have previously suggested a decline in gonorrhoea after introducing …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £138 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£23 / $37 / €30 (inc. VAT)
You can download a PDF version for your personal record.